Integration of cytokine and transcription factor signals in hematopoietic stem cell commitment

Seminars in Immunology

Volumn 23, Issue 5, 2011, Pages 326-334

  Sarrazin, Sandrine ^a,b,c   Sieweke, Michael ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Cytokine; Hematopoietic stem cell; Lineage commitment; Threshold setter; Transcription factor

Indexed keywords

CD135 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR PU 1;

CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; FEEDBACK SYSTEM; GENE DELETION; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MEGAKARYOCYTE ERYTHROID PROGENITOR; MULTIPOTENT STEM CELL; NONHUMAN; PHENOTYPE; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS; STOCHASTIC MODEL;

CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL; TRANSCRIPTION FACTORS;

EID: 82555172154     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.08.011     Document Type: Review

References (100)

1. Metcalf D. Hematopoietic cytokines. Blood 2008, 111(2):485-491.
2. Laiosa C.V., Stadtfeld M., Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol 2006, 24:705-738.
3. Metcalf D. On hematopoietic stem cell fate. Immunity 2007, 26(6):669-673.
4. Sarrazin S., Fukao T., Mossadegh N., Aziz A., Mourcin F., Vanhille L., et al. MafB restricts M-CSF dependent myeloid commitment divisions of hematopoietic stem cells. Cell 2009, 138(1):1-14.
5. Pixley F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004, 14(11):628-638.
6. Metcalf D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood 1998, 92(2):345-347. [discussion 352].
7. Enver T., Heyworth C.M., Dexter T.M. Do stem cells play dice?. Blood 1998, 92(2):348-351. [discussion 352].
8. Lin C.S., Lim S.K., D'Agati V., Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 1996, 10(2):154-164.
9. Wu H., Liu X., Jaenisch R., Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995, 83(1):59-67.
10. de Sauvage F.J., Carver-Moore K., Luoh S.M., Luoh S.M., Ryan A., Dowd M., et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996, 183(2):651-656.
11. Lieschke G.J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994, 84(6):1737-1746.
12. Cecchini M.G., Dominguez M.G., Mocci S., Wetterwald A., Felix R., Fleisch H., et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994, 120(6):1357-1372.
13. Naito M., Hayashi S., Yoshida H., Nishikawa S., Shultz L.D., Takahashi K. Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Am J Pathol 1991, 139(3):657-667.
14. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345(6274):442-444.
15. Stanley E., Lieschke G.J., Grail D., Metcalf D., Hodgson G., Gall J.A., et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 1994, 91(12):5592-5596.
16. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95(11):3489-3497.
17. Carvalho T.L., Mota-Santos T., Cumano A., Demengeot J., Vieira P., Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice. J Exp Med 2001, 194(8):1141-1150.
18. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99(1):111-120.
19. Liu F., Wu H.Y., Wesselschmidt R., Kornaga T., Link D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 1996, 5(5):491-501.
20. Mackarehtschian K., Hardin J.D., Moore K.A., Boast S., Goff S.P., Lemischka I.R. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995, 3(1):147-161.
21. Sitnicka E., Bryder D., Theilgaard-Monch K., Buza-Vidas N., Adolfsson J., Jacobsen S.E. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 2002, 17(4):463-472.
22. Miller J.P., Izon D., DeMuth W., Gerstein R., Bhandoola A., Allman D. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med 2002, 196(5):705-711.
23. Seymour J.F., Lieschke G.J., Grail D., Quilici C., Hodgson G., Dunn A.R. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 1997, 90(8):3037-3049.
24. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320(5877):807-811.
25. Sitnicka E., Brakebusch C., Martensson I.L., Svensson M., Agace W.W., Sigvardsson M., et al. Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J Exp Med 2003, 198(10):1495-1506.
26. Fairbairn L.J., Cowling G.J., Reipert B.M., Dexter T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993, 74(5):823-832.
27. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997, 89(7):1033-1041.
28. Maraskovsky E., O'Reilly L.A., Teepe M., Corcoran L.M., Peschon J.J., Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997, 89(7):1011-1019.
29. Lagasse E., Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997, 89(7):1021-1031.
30. McArthur G.A., Longmore G.D., Klingler K., Johnson G.R. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. Exp Hematol 1995, 23(7):645-654.
31. Pharr P.N., Ogawa M., Hofbauer A., Longmore G.D. Expression of an activated erythropoietin or a colony-stimulating factor 1 receptor by pluripotent progenitors enhances colony formation but does not induce differentiation. Proc Natl Acad Sci U S A 1994, 91(16):7482-7486.
32. Stoffel R., Ziegler S., Ghilardi N., Ledermann B., de Sauvage F.J., Skoda R.C. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo. Proc Natl Acad Sci U S A 1999, 96(2):698-702.
33. Semerad C.L., Poursine-Laurent J., Liu F., Link D.C. A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation. Immunity 1999, 11(2):153-161.
34. McArthur G.A., Rohrschneider L.R., Johnson G.R. Induced expression of c-fms in normal hematopoietic cells shows evidence for both conservation and lineage restriction of signal transduction in response to macrophage colony-stimulating factor. Blood 1994, 83(4):972-981.
35. Borzillo G.V., Ashmun R.A., Sherr C.J. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol Cell Biol 1990, 10(6):2703-2714.
36. Bourette R.P., Grasset M.F., Mouchiroud G. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells. Oncogene 2007, 26(2):234-247.
37. Pawlak G., Grasset M.F., Arnaud S., Blanchet J.P., Mouchiroud G. Receptor for macrophage colony-stimulating factor transduces a signal decreasing erythroid potential in the multipotent hematopoietic EML cell line. Exp Hematol 2000, 28(10):1164-1173.
38. Iwasaki-Arai J., Iwasaki H., Miyamoto T., Watanabe S., Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J Exp Med 2003, 197(10):1311-1322.
39. King A.G., Kondo M., Scherer D.C., Weissman I.L. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc Natl Acad Sci U S A 2002, 99(7):4508-4513.
40. Kondo M., Scherer D.C., Miyamoto T., King A.G., Akashi K., Sugamura K., et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 2000, 407(6802):383-386.
41. Onai N., Obata-Onai A., Tussiwand R., Lanzavecchia A., Manz M.G. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J Exp Med 2006, 203(1):227-238.
42. Metcalf D., Burgess A.W. Clonal analysis of progenitor cell commitment of granulocyte or macrophage production. J Cell Physiol 1982, 111(3):275-283.
43. Rieger M.A., Hoppe P.S., Smejkal B.M., Eitelhuber A.C., Schroeder T. Hematopoietic cytokines can instruct lineage choice. Science 2009, 325(5937):217-218.
44. Akashi K., He X., Chen J., Iwasaki N., Niu C., Steenhard B., et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 2003, 101(2):383-389.
45. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 1997, 11(6):774-785.
46. Miyamoto T., Iwasaki H., Reizis B., Ye M., Graf T., Weissman I.L., et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 2002, 3(1):137-147.
47. Takano H., Ema H., Sudo K., Nakauchi H. Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med 2004, 199(3):295-302.
48. Wu M., Kwon H.Y., Rattis F., Blum J., Zhao C., Ashkenazi R., et al. Imaging hematopoietic precursor division in real time. Cell Stem Cell 2007, 1(5):541-554.
49. Arinobu Y., Mizuno S., Chong Y., Shigematsu H., Iino T., Iwasaki H., et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007, 1(4):416-427.
50. Iwasaki H., Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007, 26(6):726-740.
51. Cantor A.B., Orkin S.H. Hematopoietic development: a balancing act. Curr Opin Genet Dev 2001, 11(5):513-519.
52. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462(7273):587-594.
53. Sieweke MH. Coordiationed control of the cell cycle and cellular identity in hematopoietic stem cells. Cell Cycle, in press.
54. Till J.E., McCulloch E.A., Siminovitch L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc Natl Acad Sci U S A 1964, 51:29-36.
55. Chang H.H., Hemberg M., Barahona M., Ingber D.E., Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008, 453(7194):544-547.
56. Cross M.A., Enver T. The lineage commitment of haemopoietic progenitor cells. Curr Opin Genet Dev 1997, 7(5):609-613.
57. Cross M.A., Heyworth C.M., Dexter T.M. How do stem cells decide what to do?. Ciba Found Symp 1997, 204:3-14. [discussion 14-18].
58. Enver T., Pera M., Peterson C., Andrews P.W. Stem cell states, fates, and the rules of attraction. Cell Stem Cell 2009, 4(5):387-397.
59. Orkin S.H. Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet 2000, 1(1):57-64.
60. Bakri Y., Sarrazin S., Mayer U.P., Tillmanns S., Nerlov C., Boned A., et al. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 2005, 105(7):2707-2716.
61. Dahl R., Walsh J.C., Lancki D., Laslo P., Iyer S.R., Singh H., et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003, 4(10):1029-1036.
62. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126(4):755-766.
63. Iwasaki H., Mizuno S., Arinobu Y., Ozawa H., Mori Y., Shigematsu H., et al. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 2006, 20(21):3010-3021.
64. Sieweke M.H., Graf T. A transcription factor party during blood cell differentiation. Curr Opin Genet Dev 1998, 8(5):545-551.
65. Loose M., Swiers G., Patient R. Transcriptional networks regulating hematopoietic cell fate decisions. Curr Opin Hematol 2007, 14(4):307-314.
66. Soneji S., Huang S., Loose M., Donaldson I.J., Patient R., Gottgens B., et al. Inference, validation, and dynamic modeling of transcription networks in multipotent hematopoietic cells. Ann N Y Acad Sci 2007, 1106:30-40.
67. Zernicka-Goetz M., Huang S. Stochasticity versus determinism in development: a false dichotomy?. Nat Rev Genet 2010, 11(11):743-744.
68. Chiba T., Ikawa Y., Todokoro K. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res 1991, 19(14):3843-3848.
69. Zon L.I., Youssoufian H., Mather C., Lodish H.F., Orkin S.H. Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci U S A 1991, 88(23):10638-10641.
70. Carotta S., Dakic A., D'Amico A., Pang S.H., Greig K.T., Nutt S.L., et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 2010, 32(5):628-641.
71. Hohaus S., Petrovick M.S., Voso M.T., Sun Z., Zhang D.E., Tenen D.G. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol 1995, 15(10):5830-5845.
72. Smith L.T., Hohaus S., Gonzalez D.A., Dziennis S.E., Tenen D.G., 1 P.U. (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 1996, 88(4):1234-1247.
73. Zhang D.E., Hetherington C.J., Chen H.M., Tenen D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 1994, 14(1):373-381.
74. Behre G., Whitmarsh A.J., Coghlan M.P., Hoang T., Carpenter C.L., Zhang D.E., et al. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem 1999, 274(8):4939-4946.
75. Krysinska H., Hoogenkamp M., Ingram R., Wilson N., Tagoh H., Laslo P., et al. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene. Mol Cell Biol 2007, 27(3):878-887.
76. Palani S., Sarkar C.A. Positive receptor feedback during lineage commitment can generate ultrasensitivity to ligand and confer robustness to a bistable switch. Biophys J 2008, 95(4):1575-1589.
77. Iida S., Watanabe-Fukunaga R., Nagata S., Fukunaga R. Essential role of C/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes. Genes Cells 2008, 13(4):313-327.
78. Laouar Y., Welte T., Fu X.Y., Flavell R.A. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 2003, 19(6):903-912.
79. Esashi E., Wang Y.H., Perng O., Qin X.F., Liu Y.J., Watowich S.S. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 2008, 28(4):509-520.
80. Shibata Y., Berclaz P.Y., Chroneos Z.C., Yoshida M., Whitsett J.A., Trapnell B.C. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001, 15(4):557-567.
81. Bryder D., Rossi D.J., Weissman I.L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 2006, 169(2):338-346.
82. Kondo M., Wagers A.J., Manz M.G., Prohaska S.S., Scherer D.C., Beilhack G.F., et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 2003, 21:759-806.
83. Forsberg E.C., Serwold T., Kogan S., Weissman I.L., Passegue E. New evidence supporting megakaryocyte-erythrocyte potential of Flk2/Flt3+ multipotent hematopoietic progenitors. Cell 2006, 126(2):415-426.
84. Mansson R., Hultquist A., Luc S., Yang L., Anderson K., Kharazi S., et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 2007, 26(4):407-419.
85. Buza-Vidas N., Luc S., Jacobsen S.E. Delineation of the earliest lineage commitment steps of haematopoietic stem cells: new developments, controversies and major challenges. Curr Opin Hematol 2007, 14(4):315-321.
86. Schmid M.A., Kingston D., Boddupalli S., Manz M.G. Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev 2010, 234(1):32-44.
87. Ryan G.R., Dai X.-M., Dominguez M.G., Tong W., Chuan F., Chisholm O., et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1op/Csf1op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001, 98(1):74-84.
88. Adams G.B., Scadden D.T. The hematopoietic stem cell in its place. Nat Immunol 2006, 7(4):333-337.
89. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 8(4):290-301.
90. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006, 6(2):93-106.
91. Metcalf D. Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels. Immunology 1971, 21(3):427-436.
92. Roth P., Bartocci A., Stanley E.R. Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo. J Immunol 1997, 158(8):3874-3880.
93. Challen G.A., Boles N.C., Chambers S.M., Goodell M.A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 2010, 6(3):265-278.
94. Dykstra B., Kent D., Bowie M., McCaffrey L., Hamilton M., Lyons K., et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 2007, 1(2):218-229.
95. Jordan C.T., Lemischka I.R., Clonal and systemic analysis of long-term hematopoiesis in the mouse Genes Dev 1990, 4(2):220-232.
96. Morita Y., Ema H., Nakauchi H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 2010, 207(6):1173-1182.
97. Muller-Sieburg C.E., Cho R.H., Thoman M., Adkins B., Sieburg H.B. Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. Blood 2002, 100(4):1302-1309.
98. Schroeder T. Hematopoietic stem cell heterogeneity: subtypes, not unpredictable behavior. Cell Stem Cell 2010, 6(3):203-207.
99. Chen H., Ray-Gallet D., Zhang P., Hetherington C.J., Gonzalez D.A., Zhang D.E., et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 1995, 11(8):1549-1560.
100. Leddin M., Perrod C., Hoogenkamp M., Ghani S., Assi S., Heinz S., et al. Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 2011, 117(10):2827-2838.